Eli Lilly and Company

LLY.F·Frankfurt
Compare
1,139.40−2.60 (−0.23%)today
As of Oct 21, 8:00 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,142.00
Open1,139.40
Day range—
52-week range685.301,139.40
Off day high0.00%
Off 52-week high0.00%
Volume5.00
Avg. volume (3M)264
Market cap1.02T
EPS (TTM)25.54
Forward P/E53.69
P/E ratio (TTM)44.61
Dividend yield0.52% (5.95)
Beta (5Y)—
Shares outstanding891.36M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
LLY.F BMY BIIB ABBV.NE AZN NVO
Market cap 1.02T 125.99B 35.92B 686.07B 261.82B 173.66B
P/E (TTM) 44.6 13.6 43.2 206.9 25.2 9.6
Forward P/E 53.7 9.3 14.8 — 14.9 11.5
Price/book 33.6 5.6 1.9 -19.1 5.2 5.3
Dividend yield 0.52% 4.09% — 2.95% 1.90% 4.57%
1-year change +58.95% +38.48% +64.57% +24.96% +1.43% −26.28%
Today −0.23% +4.84% +4.12% 0.00% +2.97% +2.42%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All LLY.F news ›
The Motley Fool·Negative

Is Eli Lilly Stock a Buy Right Now?

Eli Lilly is growing quickly, lowering realized prices, and building its next wave of drugs. Here's what the numbers say about margins, valuation, and the catalysts that matter next. Eli Lilly (LLY -0.73%) is expanding access at lower…

Trefis·

Is Eli Lilly Stock Too Dependent On Two Drugs?

Two drugs, Mounjaro and Zepbound, accounted for $14.9 billion of Eli Lilly’s (LLY) $23.0 billion in revenue during fiscal Q2 2026. This leaves Eli Lilly relying on two medicines for most of its sales at a time when the price it gets for…

From articles in the 4Search news index.

In the news

1,414mentions in 30 days
299with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.